Cochrane Abstracts
Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐fibrinolytic Use for Minimising Perioperative Allogeneic Blood Transfusion." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439219/all/Anti‐fibrinolytic_use_for_minimising_perioperative_allogeneic_blood_transfusion.
Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439219/all/Anti‐fibrinolytic_use_for_minimising_perioperative_allogeneic_blood_transfusion. Accessed January 20, 2026.
Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439219/all/Anti‐fibrinolytic_use_for_minimising_perioperative_allogeneic_blood_transfusion
Anti‐fibrinolytic Use for Minimising Perioperative Allogeneic Blood Transfusion [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439219/all/Anti‐fibrinolytic_use_for_minimising_perioperative_allogeneic_blood_transfusion.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion
ID - 439219
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439219/all/Anti‐fibrinolytic_use_for_minimising_perioperative_allogeneic_blood_transfusion
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
